Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesGoodwillGoodwill & IntangiblesIntangiblesLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Rxo (RXO) Current Assets (2021 - 2025)

Rxo (RXO) has disclosed Current Assets for 5 consecutive years, with -$2.0 billion as the latest value for Q4 2025.

  • For the quarter ending Q4 2025, Current Assets fell 246.38% year-over-year to -$2.0 billion, compared with a TTM value of $1.2 billion through Sep 2025, down 4.3%, and an annual FY2025 reading of -$2.0 billion, down 246.38% over the prior year.
  • Current Assets was -$2.0 billion for Q4 2025 at Rxo, down from $1.2 billion in the prior quarter.
  • Across five years, Current Assets topped out at $1.3 billion in Q4 2024 and bottomed at -$2.0 billion in Q4 2025.
  • Average Current Assets over 5 years is $855.6 million, with a median of $1.0 billion recorded in 2022.
  • The sharpest move saw Current Assets skyrocketed 68.22% in 2024, then plummeted 246.38% in 2025.
  • Year by year, Current Assets stood at $1.1 billion in 2021, then dropped by 4.99% to $1.0 billion in 2022, then decreased by 22.64% to $796.0 million in 2023, then surged by 68.22% to $1.3 billion in 2024, then tumbled by 246.38% to -$2.0 billion in 2025.
  • Business Quant data shows Current Assets for RXO at -$2.0 billion in Q4 2025, $1.2 billion in Q3 2025, and $1.2 billion in Q2 2025.